Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology ...

Sanofi (SNY) has released an update. Sanofi’s Dupixent has received EU approval as the first treatment for children aged one to 11 with ...

Eupraxia Pharmaceuticals (EPRX)announced additional positive clinical data from its RESOLVE Phase 1b/2a trial, which is evaluating the safety and efficacy of EP-104GI as a treatment for eosinophilic ...

Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

The safety results from the EoE KIDS study were consistent with the known safety profile of Dupixent in adolescents and ...

Eosinophilic gastroenteritis (EGE) is characterized by dense eosinophilic inflammation of one or several digestive tract sections. The symptoms include abdominal pain, weight loss, vomiting and ...

Background: Gastroesophageal reflux occurs mainly during the daytime in patients with Los Angeles grade A esophagitis, but predominantly during the night in patients with grade C and D esophagitis.

We present a case of a 34-year-old man with long-term diagnosis of eosinophilic oesophagitis (EoE ... well as joint symptoms after 3 months of treatment with tofacitinib. Upper endoscopy performed ...

redstone120yahoo.com.tw Eosinophilic gastroenteritis (EG) is an uncommon gastrointestinal tract disease, and diagnosis can be difficult. A combination of acute or recurrent abdominal pain with ...

Get better recommendations Make better investments.

Rick Rhoades and Andrew LaCombe join Tia Trudgeon and Elizabeth Peterson on Upper Michigan Today to talk about football, Packers-Lions schedule conflicts, and why FOX UP can't broadcast every game.